TY  - CHAP
M1  - Book, Section
TI  - Cost-Effectiveness in Interventional Cardiology
A1  - Kansara, Pranav
A1  - Weiss, Sandra
A1  - Weintraub, William S.
A2  - Samady, Habib
A2  - Fearon, William F.
A2  - Yeung, Alan C.
A2  - King III, Spencer B.
PY  - 2017
T2  - Interventional Cardiology, 2e
AB  - The  management  of  cardiovascular  diseases,  especially  coronary  artery  disease,  has  been  revolutionized  after  Dr.  Mason  Sones  performed  the  first  coronary  angiography  in  1960  and  Dr.  Andreas  Gruentzig  pioneered  percutaneous  coronary  intervention  in  1977.  Since  1977,  percutaneous  techniques  for  coronary  angioplasty  have  significantly  evolved.  Interventional  cardiology  has  emerged  as  a  subspecialty  of  cardiology  with  tremendous  potential  of  impacting  patient  outcomes  in  a  broad  spectrum  of  cardiovascular  diseases  including,  but  not  limited  to,  acute  coronary  syndromes,  stable  coronary  artery  disease,  heart  failure  syndromes,  and  valvular  heart  diseases.  From  the  development  of  ever-improving  coronary  interventional  equipements  and  techniques  to  facilitate  treatment  of  the  most  complex  coronary  disease  to  the  introduction  of  catheter-based  therapy  for  nonoperable  aortic  stenosis,  interventional  cardiology  has  seen  a  major  transformation  in  therapeutic  possibilities  over  the  last  decade,  and  the  continuously  expanding  horizon  of  interventional  cardiology  well  demonstrates  its  potential  beyond  just  coronary  intervention  as  first  witnessed  in  1977.  Nonetheless,  selecting  a  specific  therapy  and  offering  it  to  the  right  patient  become  challenging  in  our  society  of  limited  resources.  Careful  evaluation  of  available  evidence  becomes  vital  in  determining  the  appropriateness  of  a  specific  intervention,  considering  both  clinical  efficacy  and  cost-effectiveness.  Cost-effectiveness  of  the  most  significant  therapeutic  developments  in  interventional  cardiology  over  the  last  2  decades  is  reviewed  in  this  chapter.  A  basic  approach  in  cost-effectiveness  analysis  is  briefly  reviewed  here.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/20
UR  - accesscardiology.mhmedical.com/content.aspx?aid=1146607465
ER  -